trifluoperazine has been researched along with Depression, Endogenous in 37 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current episode of major depression, were studied in a double-blind, crossover trial of placebo and the following four active medications: alprazolam (average dose, 4." | 9.06 | Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. ( Cowdry, RW; Gardner, DL, 1988) |
| "Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current episode of major depression, were studied in a double-blind, crossover trial of placebo and the following four active medications: alprazolam (average dose, 4." | 5.06 | Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. ( Cowdry, RW; Gardner, DL, 1988) |
| "A 50-year-old man presented with hyperosmolar non-ketotic diabetic coma associated with the neuroleptic malignant syndrome (NMS) after intramuscular treatment with haloperidol." | 3.68 | Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma. ( Balzan, M; Cacciottolo, JM, 1992) |
| "Dysphagia is a potentially life-threatening complication of drug-induced parkinsonism." | 1.29 | Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. ( Bashford, G; Bradd, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (75.68) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, R | 1 |
| Chatterjee, A | 1 |
| Chaudhury, S | 1 |
| BACSIK, EJ | 1 |
| LESSE, S | 1 |
| PARE, CM | 1 |
| REES, L | 1 |
| SAINSBURY, MJ | 1 |
| HELOU, OA | 1 |
| HUTCHINSON, JT | 1 |
| SMEDBERG, D | 1 |
| BETZ, H | 1 |
| GROSS-GORTON, VE | 1 |
| OBARRIO, JM | 1 |
| FERRERO, RG | 1 |
| FABREGAS, G | 1 |
| GRATTAROLA, FR | 1 |
| ROSSO, G | 1 |
| ROVERA, GG | 1 |
| PIOT, C | 1 |
| LINGL, FA | 1 |
| WALLING, RG | 1 |
| VILKIN, MI | 1 |
| STORROW, HA | 1 |
| TEJEDORPASCUAL, F | 1 |
| SANTIAGO, RA | 1 |
| GALINDEZANTELO, W | 1 |
| MARINDEPAGAN, N | 1 |
| RAMSAY, RW | 1 |
| BAHREY, M | 1 |
| ROBINSON, B | 1 |
| STILSON, DW | 1 |
| KOPELL, BS | 1 |
| MENA, A | 1 |
| HEISTAD, G | 1 |
| SCHIELE, BC | 1 |
| JANECEK, J | 1 |
| SMITH, ME | 1 |
| CHASSAN, JB | 1 |
| MACCAIG, JN | 1 |
| EDMONDSON, JS | 1 |
| WINKELMANN, W | 1 |
| LLOYD, JT | 1 |
| WALKER, DR | 1 |
| MAZZA, PA | 1 |
| Erfurth, A | 1 |
| Schmauss, M | 2 |
| Dassylva, B | 1 |
| Bashford, G | 1 |
| Bradd, P | 1 |
| Renwick, DS | 1 |
| Chandraker, A | 1 |
| Bannister, P | 1 |
| Trachman, SB | 1 |
| Balzan, M | 1 |
| Cacciottolo, JM | 1 |
| Förstl, H | 1 |
| Zagorski, A | 1 |
| Pohlmann-Eden, B | 1 |
| Komoroski, RA | 1 |
| Newton, JE | 1 |
| Karson, C | 1 |
| Cardwell, D | 1 |
| Sprigg, J | 1 |
| Pandey, GN | 1 |
| Janicak, PG | 1 |
| Javaid, JI | 1 |
| Davis, JM | 1 |
| Cowdry, RW | 1 |
| Gardner, DL | 1 |
| Frances, A | 1 |
| Siris, SG | 1 |
| Kapfhammer, HP | 1 |
| Meyr, P | 1 |
| Hoff, P | 1 |
| Lieberman, JA | 1 |
| Kane, JM | 1 |
| Reife, R | 1 |
3 reviews available for trifluoperazine and Depression, Endogenous
| Article | Year |
|---|---|
[NEUROLOGY].
Topics: Anticonvulsants; beta-Aminoethyl Isothiourea; Coma; Depression; Depressive Disorder; Epilepsy; Human | 1963 |
[Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
Topics: Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Monoamine Oxidase | 1993 |
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clomipramine; Clorgyline; Depressive Disorder; Female; Humans; | 1986 |
1 trial available for trifluoperazine and Depression, Endogenous
| Article | Year |
|---|---|
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Topics: Adult; Alprazolam; Ambulatory Care; Borderline Personality Disorder; Carbamazepine; Clinical Trials | 1988 |
33 other studies available for trifluoperazine and Depression, Endogenous
| Article | Year |
|---|---|
Withdrawal symptoms of trifluoperazine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Citalopram; Depressive Disorde | 2008 |
Treatment of depression-anxiety in office patients with combination of tranylcypromine and trifluoperazine.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Psychopharmacology; Tranylcypromine; Tr | 1960 |
Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
Topics: Cyclopropanes; Depression; Depressive Disorder; Humans; Tranquilizing Agents; Tranylcypromine; Trifl | 1961 |
Differentiation of two genetically specific types of depression by the response to anti-depressants.
Topics: Antidepressive Agents; Depression; Depressive Disorder; Imipramine; Iproniazid; Isocarboxazid; Monoa | 1962 |
[Psychopharmacological treatment of combined anxiety and depression].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Humans; Psychopharmacology; Tranylcypro | 1962 |
Treatment of depression: a comparative study of E.C.T. and six drugs.
Topics: Antidepressive Agents; Chlorprothixene; Depression; Depressive Disorder; Electroconvulsive Therapy; | 1963 |
[Ambulant treatment of depressive states with Jatrosom].
Topics: Depression; Depressive Disorder; Humans; Tranylcypromine; Trifluoperazine | 1963 |
COMBINED TRANYLPROMINE-TRIFLUOPERAZINE THERAPY INNEWLY ADMITTED DEPRESSED PATIENTS.
Topics: Depression; Depressive Disorder; Hospitalization; Humans; Tranylcypromine; Trifluoperazine | 1963 |
[STUDIES ABOUT A NEW DRUG ASSOCIATION].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Humans; Neurotic Disorders; Toxicology; | 1963 |
[BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES].
Topics: Depression; Depressive Disorder; Humans; Mental Disorders; Monoamine Oxidase Inhibitors; Tranylcypro | 1963 |
COMBINED DRUG THERAPY COMPARED WITH ELECTRIC SHOCK IN PSYCHOTIC DEPRESSIONS.
Topics: Bipolar Disorder; Depression; Depressive Disorder; Depressive Disorder, Major; Electroconvulsive The | 1964 |
DEPRESSIONS... THEIR MANAGEMENT AND TREATMENT.
Topics: Amitriptyline; Amobarbital; Bipolar Disorder; Depression; Depressive Disorder; Electroconvulsive The | 1964 |
COMPARATIVE CHEMOTHERAPEUTIC TRIAL IN TREATMENT OF CHRONIC BORDERLINE PATIENTS.
Topics: Antidepressive Agents; Anxiety; Benactyzine; Depression; Depressive Disorder; Diazepam; Humans; Mepr | 1964 |
DEPRESSION MASQUERADING AS APATHY.
Topics: Amitriptyline; Apathy; Depression; Depressive Disorder; Electronarcosis; Humans; Imipramine; Perphen | 1964 |
COMBINED ANTIDEPRESSANT-TRANQUILIZER REGIMEN IN DEPRESSED PSYCHOTICS.
Topics: Antidepressive Agents; Depression; Depressive Disorder; Drug Therapy; Mental Disorders; Psychotic Di | 1964 |
EFFECT OF AN ANTIDEPRESSANT DRUG ON CLINIC ATTENDANCE OF ALCOHOLICS.
Topics: Alcoholics; Alcoholism; Antidepressive Agents; Depression; Depressive Disorder; Drug Therapy; Humans | 1964 |
THE RECOGNITION OF VISUAL SIGNALS IN THE PRESENCE OF VISUAL NOISE BY PSYCHIATRIC PATIENTS.
Topics: Aggression; Bipolar Disorder; Chlorpromazine; Depression; Depressive Disorder; Form Perception; Huma | 1964 |
A COMPARISON OF TRANYLCYPROMINE ALONE WITH TRANYLCYPROMINE PLUS TRIFLUOPERAZINE IN THE TREATMENT OF CHRONIC OUTPATIENTS: A DOUBLE-BLIND CONTROLLED STUDY.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Depression; Depressive Disorder; Double-Blind Metho | 1964 |
COMPARISONS OF DIAZEPAM, CHLORPROMAZINE AND TRIFLUOPERAZINE IN A DOUBLE-BLIND CLINICAL INVESTIGATION.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Chlorpromazine; Depression; Depressive Disorder; De | 1964 |
OVERDOSE OF PARSTELIN.
Topics: Coma; Cyclopropanes; Depression; Depressive Disorder; Drug Therapy; Extrapyramidal Tracts; Propylami | 1965 |
THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY).
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Depression; Depressive Disorder; Drug Therapy; Huma | 1965 |
DEATH AFTER COMBINED DEXAMPHETAMINE AND PHENELZINE.
Topics: Cerebral Hemorrhage; Death; Depression; Depressive Disorder; Dextroamphetamine; Drug Therapy; Hypert | 1965 |
Tranylcypromine and trifluoperazine in the management of the menopausal syndrome.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Menopause; Monoamine Oxidase Inhibitors | 1962 |
Verapamil may cause depression.
Topics: Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Phene | 1993 |
Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.
Topics: Aged; Deglutition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administrat | 1996 |
Missed neuroleptic malignant syndrome.
Topics: Aged; Creatine Kinase; Depressive Disorder; Diagnostic Errors; Escherichia coli Infections; Female; | 1992 |
Buspirone-induced psychosis in a human immunodeficiency virus-infected man.
Topics: Attitude to Health; Buspirone; Clonazepam; Depressive Disorder; HIV Seropositivity; Humans; Life Cha | 1992 |
Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma.
Topics: Body Temperature Regulation; Combined Modality Therapy; Depressive Disorder; Diagnosis, Differential | 1992 |
Somatosensory evoked potentials as indicators of altered cerebral excitability during psychotropic drug treatment.
Topics: Aged; Amitriptyline; Antidepressive Agents; Arousal; Depressive Disorder; Electroencephalography; Ep | 1991 |
Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy.
Topics: Brain; Depressive Disorder; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Models, Anatomic; M | 1991 |
Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders.
Topics: Bipolar Disorder; Blood Platelets; Clonidine; Depressive Disorder; Desipramine; Humans; Imidazoline | 1989 |
Schizophrenic woman on neuroleptic medication suffers secondary depression.
Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Imipramine; Schizophrenia; Sc | 1988 |
Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression.
Topics: Antidepressive Agents; Blood Pressure; Body Weight; Depressive Disorder; Dose-Response Relationship, | 1988 |